ARMP
Armata Pharmaceuticals, Inc.Company with tickers: ARMP
CIK
921114
CUSIP
04216R102
Shares Outstanding
36,710
Website
https://www.armatapharma.com
Investor Relations
https://investor.armatapharma.com/
13F Activity (30d)
2 filings
1 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $9,574,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | — | ||||
| Operating Income | $-8,785,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-115,346,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-3.16 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-3.16 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |